< Back to scientific publications

Magazine

The efficacy of Choep chemotherapy regimen administered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneous involvement (PTCL)

Authors: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.

Date: 2013

Scope of interest: Haematology




You may also be interested in:

Magazine 5.5

Tocilizumab for patients with COVID-19pneumonia. The single-arm TOCIVID-19 prospective trial.

Authors: Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.

Date: 2020

Scope of interest: sars cov 2 therapy


Read details
Magazine 9.5

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.

Authors: Petta s

Date: Jan 2017

Scope of interest: hepatological


Read details
Report/Poster of Convention/Congress Act

Long term care: which is the most appropriate patient

Authors: Abatecola Angela Marie

Date: 2021

Scope of interest: Long term care


Read details